Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DSP-6952 (minesapride) in patients with irritable bowel syndrome with constipation
jRCT2080223404Phase 2Completed
- Sponsor
- Sumitomo Pharma
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing DSP-6952 (minesapride) with Placebo (2 arms). Primary endpoint: Composite CSBM and abdominal pain response. Started Dec 2016; status: completed.
02
Drugs
minesapride
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on jRCT2080223404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223404.